We are live on
!
Find out more
GS
Gagnon Securities Portfolio holdings
AUM
$519M
1-Year Est. Return
44.91%
This Fund
S&P 500
This Quarter
Est. Return
-22.02%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$477M
AUM Growth
-$136M
(-22%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
110
New
7
Increased
59
Reduced
28
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yext
YEXT
|
+$6.12M |
| 2 |
BioLife Solutions
BLFS
|
+$2.82M |
| 3 |
SCWX
SecureWorks Corp Class A Common Stock
SCWX
|
+$2.38M |
| 4 |
Protolabs
PRLB
|
+$2.36M |
| 5 |
CareDx
CDNA
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alpha and Omega Semiconductor
AOSL
|
+$2.74M |
| 2 |
ExxonMobil
XOM
|
+$1.45M |
| 3 |
Pacira BioSciences
PCRX
|
+$1.08M |
| 4 |
The Ensign Group
ENSG
|
+$951K |
| 5 |
Navigator Holdings
NVGS
|
+$490K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.04% |
| 2 | Technology | 21.49% |
| 3 | Industrials | 15.19% |
| 4 | Energy | 10.52% |
| 5 | Consumer Discretionary | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pacira BioSciences
PCRX
$979M
| $34.7M | 7.26% |
594,392
-16,541
| -3% | -$1.08M |
|
|
AL
2
DELISTED
Air Lease Corp
AL
| $31.9M | 6.68% |
953,624
-3,591
| -0.4% | -$136K |
|
|
3
The Ensign Group
ENSG
$10.4B
| $26.2M | 5.49% |
356,654
-11,920
| -3% | -$951K |
|
|
4
Navigator Holdings
NVGS
$1.27B
| $21.8M | 4.57% |
1,931,721
-37,878
| -2% | -$490K |
|
|
5
CareDx
CDNA
$2.35B
| $21.1M | 4.42% |
981,797
+64,577
| +7% | +$1.79M |
|
6
Enterprise Products Partners
EPD
$81.6B
| $19.2M | 4.03% |
789,161
-8,284
| -1% | -$218K |
|
|
EVA
7
DELISTED
Enviva Inc.
EVA
| $16.7M | 3.5% |
292,068
-5,219
| -2% | -$393K |
|
8
FIVE9
FIVN
$2.27B
| $14.2M | 2.98% |
156,222
+3,102
| +2% | +$314K |
|
9
Intuitive Surgical
ISRG
$133B
| $13.7M | 2.88% |
68,398
-1,064
| -2% | -$250K |
|
10
BlackLine
BL
$1.79B
| $13.1M | 2.74% |
196,440
+7,875
| +4% | +$539K |
|
|
ETWO
11
DELISTED
E2open Parent Holdings
ETWO
| $12.8M | 2.68% |
1,642,238
-2,184
| -0.1% | -$17.5K |
|
|
LL
12
DELISTED
LL Flooring Holdings, Inc.
LL
| $12.6M | 2.65% |
1,348,157
+42,056
| +3% | +$514K |
|
13
Ameresco
AMRC
$1.36B
| $12.4M | 2.61% |
273,272
-2,567
| -0.9% | -$143K |
|
|
14
Alpha and Omega Semiconductor
AOSL
$974M
| $12.1M | 2.55% |
364,408
-67,022
| -16% | -$2.74M |
|
15
CarMax
KMX
$8.04B
| $11.9M | 2.49% |
131,146
+5,440
| +4% | +$512K |
|
|
16
Yext
YEXT
$574M
| $11.8M | 2.48% |
2,479,073
+1,101,973
| +80% | +$6.12M |
|
|
SCWX
17
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $11.2M | 2.35% |
1,033,446
+209,770
| +25% | +$2.38M |
|
18
Equinix
EQIX
$104B
| $11M | 2.32% |
16,815
-88
| -0.5% | -$61K |
|
|
NEWR
19
DELISTED
New Relic, Inc.
NEWR
| $10.9M | 2.29% |
217,938
-42
| -0% | -$2.33K |
|
20
QuidelOrtho
QDEL
$1.19B
| $10.6M | 2.23% |
109,428
-3,136
| -3% | -$320K |
|
|
PROF
21
Profound Medical
PROF
$290M
| $9.68M | 2.03% |
1,327,532
+3,197
| +0.2% | +$25.3K |
|
|
IRBT
22
DELISTED
iRobot
IRBT
| $8.31M | 1.74% |
226,262
+23,223
| +11% | +$1.12M |
|
|
23
BioLife Solutions
BLFS
$1.65B
| $7.89M | 1.65% |
571,679
+192,173
| +51% | +$2.82M |
|
|
ZUO
24
DELISTED
Zuora, Inc.
ZUO
| $7.73M | 1.62% |
863,868
+134,648
| +18% | +$1.5M |
|
|
25
Protolabs
PRLB
$2.16B
| $7.38M | 1.55% |
154,214
+50,797
| +49% | +$2.36M |
|
Similar funds
CI
WPP
CFM
LHC
AAM
RCI
SCM
SC
Gagnon Securities's Q2 2022 Portfolio in Review
As of Q2 2022, Gagnon Securities held 110 positions worth $477M, down 22% from $613M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Gagnon Securities deployed $15.9M of net new capital in Q2 2022, opening 7 new positions and adding to 59 existing holdings. Its largest new stake was Heron Therapeutics: 367,514 shares worth $1.02M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Alpha and Omega Semiconductor, an estimated $2.74M trimmed.
- Gagnon Securities's largest Q2 2022 buy was Heron Therapeutics: 367,514 shares worth $1.02M.
- Gagnon Securities added most to Yext in Q2 2022, an estimated $6.12M increase.
- Gagnon Securities's biggest Q2 2022 reduction was Alpha and Omega Semiconductor, cutting an estimated $2.74M.
- Gagnon Securities fully exited NVIDIA in Q2 2022, selling an estimated $324K.
- Gagnon Securities's ten largest holdings make up 45% of its $477M portfolio in Q2 2022.
- Gagnon Securities opened 7 new positions and closed 9 in Q2 2022.
- Gagnon Securities's portfolio value fell 22% quarter-over-quarter to $477M.
Based on Gagnon Securities's 13F filing for Q2 2022, filed 1 Aug 2022.